| Literature DB >> 32154414 |
Josephat K Bungei1,2, Victor A Mobegi2, Steven G Nyanjom1.
Abstract
INTRODUCTION: Plasmodium falciparum relies on gametocytogenesis to transmit from humans to mosquitoes. Gametocyte development 1 (Pfgdv1) is an upstream activator and epigenetic controller of gametocytogenesis. The emergence of drug resistance is a major public health concern and this requires the development of new strategies that target the transmission of malaria. As a putative drug target, Pfgdv1 has not been characterized to identify its polymorphisms and alleles under selection and how such polymorphisms influence protein structure.Entities:
Keywords: Biochemistry; Bioinformatics; DNA sequencing; Gametocytogenesis; Gene mutation; Molecular biology; Parasitology; Pfgdv1; Plasmodium falciparum; Selection analysis; Single-nucleotide polymorphism
Year: 2020 PMID: 32154414 PMCID: PMC7056661 DOI: 10.1016/j.heliyon.2020.e03453
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Characteristics of malaria patients and samples collected.
| Statistics | Age | Blood volume drawn (ml) | Parasitaemia (p/μl) | |
|---|---|---|---|---|
| Mean | 30.47 | 2.35 | 29060.67 | |
| Standard Deviation | 5.11 | 0.59 | 22920.31 | |
| Range | 19.00 | 2.50 | 74960.00 | |
| Minimum | 21.00 | 1.50 | 5040.00 | |
| Maximum | 40.00 | 4.00 | 80000.00 | |
| Count (N) | 30.00 | 30.00 | 30.00 | |
| Females | 18 | 60 | 26434 ± 19020.28 | F (1,28) = 0.582, p = 0.452 |
| Males | 12 | 40 | 33000 ± 27317.04 | |
| 20–25 Years | 6 | 20 | 37846 ± 26433.69 | F (3,26) = 1.339, p = 0.283 |
| 26–30 Years | 8 | 26.7 | 20542 ± 9792.89 | |
| 31–35 Years | 10 | 33.3 | 23960 ± 19465.42 | |
| 36–40 Years | 6 | 20 | 40133 ± 33527.06 | |
| Baringo County | 10 | 33.3 | 39164 ± 21733.83 | F (2,27) = 1.712, p = 0.200 |
| Uasin Gishu County | 10 | 33.3 | 20984 ± 19020.28 | |
| Nandi County | 10 | 33.3 | 27034 ± 25848.98 | |
Figure 1The distribution of parasitaemia levels of 30 patients according to age groups, gender, and study sites.
SNPs identified in Pfgdv1 among secondary sequences from PlasmoDB.
| SNPs | Alleles | Amino Acid Change | Phenotypes | % Calls | Isolate Count | ||
|---|---|---|---|---|---|---|---|
| Reference (3D7) | Minor Allele Frequency (MAF) | Genetic Code | Amino Acid | ||||
| c.650C > A | C | C (39%) | p.P217H | non- synonymous | non-conservative | 87.6 | 207 |
| c.1193G > A | G | A (25%) | p.R398Q | non- synonymous | non- conservative | 83.9 | 205 |
| c.1249C > A | C | C (18%) | p.H417N | non- synonymous | non-conservative | 83.5 | 202 |
| c.1491T > A | T | A (10%) | p.D497E | non- synonymous | conservative | 89 | 208 |
| c.1542A > T | A | A (26%) | p.S514S | Synonymous | conservative | 90.4 | 200 |
SNPs identified in Pfgdv1 among primary sequences from Kenyan Isolates.
| SNPs | Alleles | Amino Acid Change | Phenotypes | % Calls | Isolate Count | ||
|---|---|---|---|---|---|---|---|
| Reference (3D7) | Minor Allele Frequency (MAF) | Genetic Code | Amino Acid | ||||
| c.650C > A | C | C (37%) | p.P217H | non-synonymous | non-conservative | 94 | 30 |
| c.1193G > A | G | A (13%) | p.R398Q | non-synonymous | non-conservative | 94 | 30 |
| c.1249C > A | C | C (10%) | p.H417N | non-synonymous | non-conservative | 94 | 30 |
| c.1491T > A | T | A (10%) | p.D497E | non-synonymous | conservative | 94 | 30 |
| c.1542A > T | A | A (20%) | p.S514S | Synonymous | conservative | 94 | 30 |
Figure 2MSA outcome visualized using Jalview to highlight four nsSNPs (p.P217H, p.R398Q, p.H417N, and p.D497E) in Pfgdv1 sequences generated from 30 primary isolates of P. falciparum (B1–B10, U1–U10, N1–N10) aligned to the reference sequence (PF3D7).
Results from Tajima's neutrality test.
| M | S | ps | Θ | π | D |
|---|---|---|---|---|---|
| 30 | 4 | 0.007 | 0.0018 | 0.0019 | 0.209 |
| 184 | 4 | 0.007 | 0.0012 | 0.0018 | 0.929 |
Abbreviations: m = number of sequences, S = number of polymorphic sites, ps = p-value (S/n), Θ = expected varariation (ps/a1), π = observed variation (nucleotide diversity), and D = the Tajima test statistic.
Selection analysis outcomes of primary data.
| Local Isolates (n = 30) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Partition | Sites | Branches | Branch Length | Selected at p ≤ 0.05 | ||||
| Tested | Total | Tested | % of total | Total | Positive | Negative | ||
| 1 | 561 | 15 | 15 | 0.00233 | 50.0% | 0.00466 | 1 | 0 |
| Nucleotide GTR | 4373.58 | -2163.75 | 23 | |||||
| Global MG94xREV | 4202.49 | -2071.06 | 30 | non-synonymous/synonymous rate ratio for ∗test∗ | ||||
| 100% @ 0.946 | ||||||||
| 217 | 0.63 | 2.38 | 0.00 | 4.00 | 0.00 | 1.68 | 361.68 | |
| 398 | 1.65 | 1.35 | 0.00 | 1.00 | 0.00 | 0.74 | 158.98 | |
| 497 | 0.02 | 2.98 | 0.00 | 1.00 | 0.00 | 0.34 | 72.17 | |
| 417 | 0.00 | 3.00 | 0.00 | 1.00 | 0.00 | 0.33 | 0.00 | |
| 514 | 1.00 | 1.69 | 1.00 | 0.00 | 1.00 | 0.00 | -214.70 | |
Selection analysis outcomes of secondary data.
| Global Isolates (n = 184) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Partition | Sites | Branches | Branch Length | Selected at p ≤ 0.05 | ||||
| Tested | Total | Tested | % of total | Total | Positive | Negative | ||
| 1 | 599 | 49 | 49 | 0.00333 | 35.30% | 0.00945 | 1 | 1 |
| Nucleotide GTR | 4890.08 | -2387.97 | 57 | |||||
| Global MG94xREV | 4706 | -2288.73 | 64 | non-synonymous/synonymous rate ratio for ∗test∗ | ||||
| 100% @ 0.328 | ||||||||
| 217 | 0.62 | 2.38 | 0.00 | 4.00 | 0.00 | 1.68 | 177.70 | |
| 497 | 0.02 | 2.98 | 0.00 | 2.00 | 0.00 | 0.67 | 70.94 | |
| 398 | 0.87 | 2.13 | 0.00 | 1.00 | 0.00 | 0.47 | 49.72 | |
| 417 | 0.00 | 3.00 | 0.00 | 5.00 | 0.00 | 1.67 | 0.00 | |
| 514 | 1.00 | 1.62 | 5.00 | 0.00 | 5.00 | 0.00 | -529.25 | |
Gibbs free-energy gaps (ddG) of nsSNPs in Pfgdv1.
| Amino Acid Position | Wild Type | Mutant Type | ddG |
|---|---|---|---|
| 217 | P | H | -2.22 |
| 398 | R | Q | 0.07 |
| 417 | H | N | 0.92 |
| 497 | D | E | 1.62 |